Shire’s new chairman will be second only woman to lead a FTSE 100Susan Kilsby, who has been on the board at Shire since leaving a career in investment banking in Share XShire’s new chairman will be second only woman to lead a FTSE 100https://pharmaphorum.com/news/shire-s-new-chairman-will-be-second-only-woman-to-lead-a-ftse-100/
Diabetes: Tackling a growing global challengeEnrique Conterno of Eli Lilly and Company addresses the growing challenge of diabetes and discusses how pooling our Share XDiabetes: Tackling a growing global challengehttps://pharmaphorum.com/views-and-analysis/diabetes-tackling-a-growing-global-challenge/
Commercialisation of biotech assets – learning from the pioneers: part oneDan Heapy brings strategic marketing expertise to critically assess the approaches taken by the biotech companies – and Share XCommercialisation of biotech assets – learning from the pioneers: part onehttps://pharmaphorum.com/views-and-analysis/commercialisation-of-biotech-assets-learning-from-the-pioneers-part-one/
How to deliver an effective global strategic brand planIn our ‘Marketing Excellence’ themed month Sunil Ramkali discusses how to deliver an effective pharmaceutical global strategic brand Share XHow to deliver an effective global strategic brand planhttps://pharmaphorum.com/views-and-analysis/how-to-deliver-an-effective-global-strategic-brand-plan/
Communicating diabetes to the online masses – how can pharma take advantage?Kirsty Pegram explores the opportunity presented to pharma by the global explosion of online diabetes communication. Diabetes has Share XCommunicating diabetes to the online masses – how can pharma take advantage?https://pharmaphorum.com/views-and-analysis/communicating-diabetes-to-the-online-masses-how-can-pharma-take-advantage/
Personalised medicines: challenges and opportunitiesIn our personalised medicine themed month, Duncan McHale discusses the barriers to adoption and the benefits of personalised Share XPersonalised medicines: challenges and opportunitieshttps://pharmaphorum.com/views-and-analysis/personalised-medicines-challenges-and-opportunities/
Using the human genome to guide healthcare decisionsAs our personalized medicine month continues, pharmaphorum’s Hannah Blake catches up with Michael Christman, President and CEO of Share XUsing the human genome to guide healthcare decisionshttps://pharmaphorum.com/views-and-analysis/using-the-human-genome-to-guide-healthcare-decisions/
A new regulation that we should be pleased with!Paul Gershlick explores the Falsified Medicines Directive. As a lawyer, I often plead with people: “Don’t shoot the Share XA new regulation that we should be pleased with!https://pharmaphorum.com/views-and-analysis/a-new-regulation-that-we-should-be-pleased-with/
Conducting impactful workshopsKelly Price shares her top tips on how to establish and conduct an impactful workshop. In this digital Share XConducting impactful workshopshttps://pharmaphorum.com/views-and-analysis/conducting-impactful-workshops/
